135 related articles for article (PubMed ID: 35521019)
1. A Pharmacist-Driven Glycemic Control Protocol to Reduce the Rate of Severe Hypoglycemia in High-Risk Patients.
Cook CA; Vakayil V; Pribyl K; Yerxa D; Kriz J; Case A; Meisel S; Ho T; Harmon JV
Hosp Pharm; 2022 Feb; 57(1):45-51. PubMed ID: 35521019
[No Abstract] [Full Text] [Related]
2. Pharmacist glycemic control team improves quality of glycemic control in surgical patients with perioperative dysglycemia.
Mularski KS; Yeh CP; Bains JK; Mosen DM; Hill AK; Mularski RA
Perm J; 2012; 16(1):28-33. PubMed ID: 22529756
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of a pharmacist-managed glucose collaborative practice agreement.
Pugazhenthi V; Dick TB; Call M
Am J Health Syst Pharm; 2016 Dec; 73(23 Supplement 6):S148-S154. PubMed ID: 27864238
[TBL] [Abstract][Full Text] [Related]
4. Improved postoperative blood glucose control through implementation of clinical pharmacist driven glycemic management model after colorectal surgery.
Smith NT; Xiong S; Bergquist WJ; Blader LR; Tang KK; Cima RR
Am J Surg; 2023 Jun; 225(6):1050-1055. PubMed ID: 36609079
[TBL] [Abstract][Full Text] [Related]
5. Maintaining glycemic control when transitioning from infusion insulin: a protocol-driven, multidisciplinary approach.
Ramos P; Childers D; Maynard G; Box K; Namba J; Stadalman K; Renvall M
J Hosp Med; 2010 Oct; 5(8):446-51. PubMed ID: 20945469
[TBL] [Abstract][Full Text] [Related]
6. Implementing a pharmacist consultation model for multimodal insulin therapy.
Hodges A; Hall J; Castellanos E; Laue E; Ellis T; Oelschlaeger L
Am J Health Syst Pharm; 2017 May; 74(9):e224-e229. PubMed ID: 28438827
[TBL] [Abstract][Full Text] [Related]
7. Glycemic control in the infectious diseases ward; role of clinical pharmacist interventions.
Farsaei S; Karimzadeh I; Elyasi S; Hatamkhani S; Khalili H
J Infect Dev Ctries; 2014 Apr; 8(4):480-9. PubMed ID: 24727515
[TBL] [Abstract][Full Text] [Related]
8. Impact of a Pharmacist-Driven Protocol to Improve Guideline-Concordant Prescribing of Diabetes Medications in Patients With Atherosclerotic Cardiovascular Disease: A Pilot Study.
Freudenberg DL; Covington LP; Young RB; Lopez ND; Patel MV; MacLaughlin EJ
J Pharm Pract; 2022 Feb; 35(1):80-85. PubMed ID: 32938319
[TBL] [Abstract][Full Text] [Related]
9. IMPLEMENTATION OF AN ELECTRONIC DASHBOARD WITH A REMOTE MANAGEMENT SYSTEM TO IMPROVE GLYCEMIC MANAGEMENT AMONG HOSPITALIZED ADULTS.
Sheen YJ; Huang CC; Huang SC; Huang MD; Lin CH; Lee IT; Lin SY; Sheu WH
Endocr Pract; 2020 Feb; 26(2):179-191. PubMed ID: 31557078
[No Abstract] [Full Text] [Related]
10. Effectiveness of Pharmacist and Physician Collaboration in the Treatment of Type 2 Diabetes Mellitus With Severe Insulin Resistance Using U-500 Insulin.
Hess R; Brandon S; Johnson F
South Med J; 2016 Nov; 109(11):690-693. PubMed ID: 27812708
[TBL] [Abstract][Full Text] [Related]
11. Glycemic Control and Management in Pharmacist-Led Diabetic Clinic vs. Physician-Led Diabetic Clinic.
Alghadeer SM; Alsuwayni B; Almuwayjid AK; Almadi MS; Mubarak AM; Khunayn RMB; Al-Arifi MN
Medicina (Kaunas); 2021 Dec; 58(1):. PubMed ID: 35056322
[No Abstract] [Full Text] [Related]
12. Development of a pharmacist-managed protocol for the transition from intravenous to subcutaneous insulin in critically ill adults.
Gerhardt JM; Dine SA; Foster DR; Lodolo AC; McIntire AM; Peters MJ; Rhew TA; Walroth TA
Am J Health Syst Pharm; 2022 Aug; 79(Suppl 3):S86-S93. PubMed ID: 35605142
[TBL] [Abstract][Full Text] [Related]
13. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
14. IMPROVING GLYCEMIC CONTROL SAFELY IN CRITICAL CARE PATIENTS: A COLLABORATIVE SYSTEMS APPROACH IN NINE HOSPITALS.
Maynard GA; Holdych J; Kendall H; Harrison K; Montgomery PA; Kulasa K
Endocr Pract; 2017 May; 23(5):583-593. PubMed ID: 28225315
[TBL] [Abstract][Full Text] [Related]
15. Improving IV insulin administration in a community hospital.
Magee MC
J Vis Exp; 2012 Jun; (64):e3705. PubMed ID: 22710978
[TBL] [Abstract][Full Text] [Related]
16. Impact of a hypoglycemia reduction bundle and a systems approach to inpatient glycemic management.
Maynard G; Kulasa K; Ramos P; Childers D; Clay B; Sebasky M; Fink E; Field A; Renvall M; Juang PS; Choe C; Pearson D; Serences B; Lohnes S
Endocr Pract; 2015 Apr; 21(4):355-67. PubMed ID: 25536971
[TBL] [Abstract][Full Text] [Related]
17. Intensive insulin protocol implementation and outcomes in the medical and surgical wards at a Veterans Affairs Medical Center.
Chen HJ; Steinke DT; Karounos DG; Lane MT; Matson AW
Ann Pharmacother; 2010 Feb; 44(2):249-56. PubMed ID: 20103610
[TBL] [Abstract][Full Text] [Related]
18. Prospective Study of Postoperative Glycemic Control with a Standardized Insulin Infusion Protocol after Infrainguinal Bypass and Open Abdominal Aortic Aneurysm Repair.
Steely AM; Smith L; Callas PW; Nathan MH; Lahiri JE; Stanley AC; Steinthorsson G; Bertges DJ
Ann Vasc Surg; 2017 Oct; 44():211-220. PubMed ID: 28502888
[TBL] [Abstract][Full Text] [Related]
19. Impact of pharmacist outreach on glucagon prescribing.
Whitfield N; Gregory P; Liu B; Spratt S; Smith BH
J Am Pharm Assoc (2003); 2022; 62(4):1384-1388.e1. PubMed ID: 35151583
[TBL] [Abstract][Full Text] [Related]
20. Implementation of a Pharmacist-Led Diabetes Management Protocol.
Al-Omar LT; Anderson SL; Cizmic AD; Vlasimsky TB
Am Health Drug Benefits; 2019 Feb; 12(1):14-20. PubMed ID: 30972149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
